These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28542831)

  • 21. The Utility of Supertype Clustering in Prediction for Class II MHC-Peptide Binding.
    Shen WJ; Zhang X; Zhang S; Liu C; Cui W
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30463372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
    Lee JM; McKean DJ; Watts TH
    J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling the structure of bound peptide ligands to major histocompatibility complex.
    Tong JC; Tan TW; Ranganathan S
    Protein Sci; 2004 Sep; 13(9):2523-32. PubMed ID: 15322290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemistry of peptides associated with MHC class I and class II molecules.
    Rammensee HG
    Curr Opin Immunol; 1995 Feb; 7(1):85-96. PubMed ID: 7772286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Class II HLA-peptide binding prediction using structural principles.
    Mohanapriya A; Lulu S; Kayathri R; Kangueane P
    Hum Immunol; 2009 Mar; 70(3):159-69. PubMed ID: 19187794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach.
    Nielsen M; Lundegaard C; Worning P; Hvid CS; Lamberth K; Buus S; Brunak S; Lund O
    Bioinformatics; 2004 Jun; 20(9):1388-97. PubMed ID: 14962912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformational variation in structures of classical and non-classical MHCII proteins and functional implications.
    Painter CA; Stern LJ
    Immunol Rev; 2012 Nov; 250(1):144-57. PubMed ID: 23046127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of MHC class II binding peptides: microarray and soluble MHC class II molecules.
    Gaseitsiwe S; Maeurer MJ
    Methods Mol Biol; 2009; 524():417-26. PubMed ID: 19377962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shift-invariant adaptive double threading: learning MHC II-peptide binding.
    Zaitlen N; Reyes-Gomez M; Heckerman D; Jojic N
    J Comput Biol; 2008 Sep; 15(7):927-42. PubMed ID: 18771399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hb(64-76) epitope binds in different registers and lengths to I-Ek and I-Ak.
    Vidal K; Daniel C; Vidavsky I; Nelson CA; Allen PM
    Mol Immunol; 2000 Apr; 37(5):203-12. PubMed ID: 10930627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes.
    Bordner AJ
    PLoS One; 2010 Dec; 5(12):e14383. PubMed ID: 21187956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopes.
    Racle J; Guillaume P; Schmidt J; Michaux J; Larabi A; Lau K; Perez MAS; Croce G; Genolet R; Coukos G; Zoete V; Pojer F; Bassani-Sternberg M; Harari A; Gfeller D
    Immunity; 2023 Jun; 56(6):1359-1375.e13. PubMed ID: 37023751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
    Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL
    Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NNAlign_MA; MHC Peptidome Deconvolution for Accurate MHC Binding Motif Characterization and Improved T-cell Epitope Predictions.
    Alvarez B; Reynisson B; Barra C; Buus S; Ternette N; Connelley T; Andreatta M; Nielsen M
    Mol Cell Proteomics; 2019 Dec; 18(12):2459-2477. PubMed ID: 31578220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide binding motifs for MHC class I and II molecules.
    Biddison WE; Martin R
    Curr Protoc Immunol; 2001 May; Appendix 1():Appendix 1I. PubMed ID: 18432645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide linkage to the α-subunit of MHCII creates a stably inverted antigen presentation complex.
    Schlundt A; Günther S; Sticht J; Wieczorek M; Roske Y; Heinemann U; Freund C
    J Mol Biol; 2012 Oct; 423(3):294-302. PubMed ID: 22820093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103).
    Reay PA; Kantor RM; Davis MM
    J Immunol; 1994 Apr; 152(8):3946-57. PubMed ID: 7511662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT.
    Remesh SG; Andreatta M; Ying G; Kaever T; Nielsen M; McMurtrey C; Hildebrand W; Peters B; Zajonc DM
    J Biol Chem; 2017 Mar; 292(13):5262-5270. PubMed ID: 28179428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network.
    Brusic V; Rudy G; Honeyman G; Hammer J; Harrison L
    Bioinformatics; 1998; 14(2):121-30. PubMed ID: 9545443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
    Duyar H; Dengjel J; de Graaf KL; Wiesmüller KH; Stevanović S; Weissert R
    Immunogenetics; 2005 Apr; 57(1-2):69-76. PubMed ID: 15711804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.